Matrix biology of idiopathic pulmonary fibrosis

A workshop report of the national heart, lung, and blood institute

Victor J. Thannickal, Craig A. Henke, Jeffrey C. Horowitz, Paul W. Noble, Jesse Roman, Patricia J. Sime, Yong Zhou, Rebecca G. Wells, Eric S. White, Daniel J Tschumperlin

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

A hallmark of idiopathic pulmonary fibrosis (IPF) is excessive and disordered deposition of extracellular matrix. Although the lung extracellular matrix normally plays an essential role in development and maintenance of lung tissue through reciprocal interactions with resident cells, the disordered matrix in the diseased lung is increasingly recognized as an active and important contributor to IPF pathogenesis. This working group summary from a recently conducted National Heart, Lung, and Blood Institute strategic planning workshop for IPF research highlights recent advances, challenges, and opportunities in the study of matrix biology in IPF. Particular attention is given to the composition and mechanical properties of the matrix in normal and diseased lungs, and the biochemical and biomechanical influences exerted by pathological matrix. Recently developed model systems are also summarized as key tools for advancing our understanding of matrix biology in IPF. Emerging approaches to therapeutically target the matrix in preclinical and clinical settings are discussed, as are important concepts, such as alterations of the matrix with aging and the potential for the resolution of fibrosis. Specific recommendations for future studies in matrix biology of IPF are also proposed.

Original languageEnglish (US)
Pages (from-to)1643-1651
Number of pages9
JournalAmerican Journal of Pathology
Volume184
Issue number6
DOIs
StatePublished - 2014

Fingerprint

National Heart, Lung, and Blood Institute (U.S.)
Idiopathic Pulmonary Fibrosis
Education
Lung Diseases
Extracellular Matrix
Lung
Fibrosis
Maintenance
Research

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medicine(all)

Cite this

Matrix biology of idiopathic pulmonary fibrosis : A workshop report of the national heart, lung, and blood institute. / Thannickal, Victor J.; Henke, Craig A.; Horowitz, Jeffrey C.; Noble, Paul W.; Roman, Jesse; Sime, Patricia J.; Zhou, Yong; Wells, Rebecca G.; White, Eric S.; Tschumperlin, Daniel J.

In: American Journal of Pathology, Vol. 184, No. 6, 2014, p. 1643-1651.

Research output: Contribution to journalArticle

Thannickal, VJ, Henke, CA, Horowitz, JC, Noble, PW, Roman, J, Sime, PJ, Zhou, Y, Wells, RG, White, ES & Tschumperlin, DJ 2014, 'Matrix biology of idiopathic pulmonary fibrosis: A workshop report of the national heart, lung, and blood institute', American Journal of Pathology, vol. 184, no. 6, pp. 1643-1651. https://doi.org/10.1016/j.ajpath.2014.02.003
Thannickal, Victor J. ; Henke, Craig A. ; Horowitz, Jeffrey C. ; Noble, Paul W. ; Roman, Jesse ; Sime, Patricia J. ; Zhou, Yong ; Wells, Rebecca G. ; White, Eric S. ; Tschumperlin, Daniel J. / Matrix biology of idiopathic pulmonary fibrosis : A workshop report of the national heart, lung, and blood institute. In: American Journal of Pathology. 2014 ; Vol. 184, No. 6. pp. 1643-1651.
@article{100bb37bbb05442a8433707b04d1b25e,
title = "Matrix biology of idiopathic pulmonary fibrosis: A workshop report of the national heart, lung, and blood institute",
abstract = "A hallmark of idiopathic pulmonary fibrosis (IPF) is excessive and disordered deposition of extracellular matrix. Although the lung extracellular matrix normally plays an essential role in development and maintenance of lung tissue through reciprocal interactions with resident cells, the disordered matrix in the diseased lung is increasingly recognized as an active and important contributor to IPF pathogenesis. This working group summary from a recently conducted National Heart, Lung, and Blood Institute strategic planning workshop for IPF research highlights recent advances, challenges, and opportunities in the study of matrix biology in IPF. Particular attention is given to the composition and mechanical properties of the matrix in normal and diseased lungs, and the biochemical and biomechanical influences exerted by pathological matrix. Recently developed model systems are also summarized as key tools for advancing our understanding of matrix biology in IPF. Emerging approaches to therapeutically target the matrix in preclinical and clinical settings are discussed, as are important concepts, such as alterations of the matrix with aging and the potential for the resolution of fibrosis. Specific recommendations for future studies in matrix biology of IPF are also proposed.",
author = "Thannickal, {Victor J.} and Henke, {Craig A.} and Horowitz, {Jeffrey C.} and Noble, {Paul W.} and Jesse Roman and Sime, {Patricia J.} and Yong Zhou and Wells, {Rebecca G.} and White, {Eric S.} and Tschumperlin, {Daniel J}",
year = "2014",
doi = "10.1016/j.ajpath.2014.02.003",
language = "English (US)",
volume = "184",
pages = "1643--1651",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Matrix biology of idiopathic pulmonary fibrosis

T2 - A workshop report of the national heart, lung, and blood institute

AU - Thannickal, Victor J.

AU - Henke, Craig A.

AU - Horowitz, Jeffrey C.

AU - Noble, Paul W.

AU - Roman, Jesse

AU - Sime, Patricia J.

AU - Zhou, Yong

AU - Wells, Rebecca G.

AU - White, Eric S.

AU - Tschumperlin, Daniel J

PY - 2014

Y1 - 2014

N2 - A hallmark of idiopathic pulmonary fibrosis (IPF) is excessive and disordered deposition of extracellular matrix. Although the lung extracellular matrix normally plays an essential role in development and maintenance of lung tissue through reciprocal interactions with resident cells, the disordered matrix in the diseased lung is increasingly recognized as an active and important contributor to IPF pathogenesis. This working group summary from a recently conducted National Heart, Lung, and Blood Institute strategic planning workshop for IPF research highlights recent advances, challenges, and opportunities in the study of matrix biology in IPF. Particular attention is given to the composition and mechanical properties of the matrix in normal and diseased lungs, and the biochemical and biomechanical influences exerted by pathological matrix. Recently developed model systems are also summarized as key tools for advancing our understanding of matrix biology in IPF. Emerging approaches to therapeutically target the matrix in preclinical and clinical settings are discussed, as are important concepts, such as alterations of the matrix with aging and the potential for the resolution of fibrosis. Specific recommendations for future studies in matrix biology of IPF are also proposed.

AB - A hallmark of idiopathic pulmonary fibrosis (IPF) is excessive and disordered deposition of extracellular matrix. Although the lung extracellular matrix normally plays an essential role in development and maintenance of lung tissue through reciprocal interactions with resident cells, the disordered matrix in the diseased lung is increasingly recognized as an active and important contributor to IPF pathogenesis. This working group summary from a recently conducted National Heart, Lung, and Blood Institute strategic planning workshop for IPF research highlights recent advances, challenges, and opportunities in the study of matrix biology in IPF. Particular attention is given to the composition and mechanical properties of the matrix in normal and diseased lungs, and the biochemical and biomechanical influences exerted by pathological matrix. Recently developed model systems are also summarized as key tools for advancing our understanding of matrix biology in IPF. Emerging approaches to therapeutically target the matrix in preclinical and clinical settings are discussed, as are important concepts, such as alterations of the matrix with aging and the potential for the resolution of fibrosis. Specific recommendations for future studies in matrix biology of IPF are also proposed.

UR - http://www.scopus.com/inward/record.url?scp=84901020197&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901020197&partnerID=8YFLogxK

U2 - 10.1016/j.ajpath.2014.02.003

DO - 10.1016/j.ajpath.2014.02.003

M3 - Article

VL - 184

SP - 1643

EP - 1651

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 6

ER -